Profile data is unavailable for this security.
About the company
Qingdao Vland Biotech Co., Ltd. is a China-based company which mainly develops, produces and sells enzyme preparations, micro-ecology and animal health products. The Company's main products are enzyme preparations, micro-ecology and animal health products, such as feed enzymes, industrial enzymes, food enzymes, plant micro-ecological preparations, veterinary chemicals and veterinary drugs. The Company's products are mainly used in the washing, textile, food, feed, paper, energy and pharmaceutical industries. The Company mainly distributes its products in China and overseas markets.
- Revenue in CNY (TTM)1.25bn
- Net income in CNY82.87m
- Incorporated2005
- Employees1.57k
- LocationQingdao Vland Biotech INCNo. 596-1Jiushui East Road, Laoshan DistrictQINGDAO 266100ChinaCHN
- Phone+86 53 288978071
- Fax+86 53 288966609
- Websitehttp://www.vlandgroup.com/
More ▼
Mergers & acquisitions
| Acquired company | 603739:SHH since announced | Transaction value |
|---|---|---|
| Qingdao Runbot Biotechnology Co Ltd | 6.03% | 12.79m |
Data delayed at least 15 minutes, as of May 31 2024.
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jiangsu Yahong Meditech Co Ltd | 38.05m | -420.35m | 3.43bn | 394.00 | -- | 1.49 | -- | 90.18 | -0.7375 | -0.7375 | 0.0668 | 4.03 | 0.0142 | 3.05 | 3.76 | 96,573.63 | -15.68 | -15.80 | -16.54 | -16.48 | 77.72 | 55.32 | -1,106.10 | -9,445.91 | 11.34 | -- | 0.0684 | -- | 52,594.79 | -- | -62.42 | -- | 64.28 | -- |
| Lionco Pharmaceutical Group Co Ltd | 200.39m | -144.55m | 3.60bn | 475.00 | -- | 3.92 | -- | 17.96 | -0.2071 | -0.2071 | 0.2826 | 1.27 | 0.1182 | 1.86 | 2.52 | 421,872.40 | -8.52 | 0.7396 | -9.94 | 0.9562 | 42.74 | 80.88 | -72.13 | 2.08 | 6.19 | -5.98 | 0.3512 | 521.93 | -31.95 | -34.79 | 22.65 | -- | -33.18 | -- |
| Qingdao Vland Biotech INC | 1.25bn | 82.87m | 3.65bn | 1.57k | 43.36 | 2.12 | -- | 2.91 | 0.3326 | 0.3326 | 5.02 | 6.81 | 0.4431 | 3.42 | 4.33 | 797,663.40 | 3.80 | 5.78 | 5.77 | 7.89 | 45.38 | 46.13 | 8.58 | 10.34 | 0.8387 | 149.27 | 0.2896 | 33.59 | 3.07 | 8.05 | 15.56 | -0.6507 | 24.68 | -6.89 |
| Obio Technology Shanghai Corp Ltd | 233.59m | -138.37m | 3.66bn | 731.00 | -- | 1.81 | -- | 15.66 | -0.2157 | -0.2157 | 0.3624 | 3.11 | 0.0921 | 3.37 | 2.52 | 319,545.50 | -5.45 | 0.2246 | -5.99 | 0.2514 | -9.53 | 36.72 | -59.21 | 1.48 | 2.39 | -- | 0.1103 | 0.00 | -29.69 | 35.88 | -425.90 | -- | 57.00 | -- |
| Zhejiang Starry Pharmaceutical Co Ltd | 2.27bn | 46.95m | 3.82bn | 1.85k | 81.57 | 2.17 | -- | 1.68 | 0.1368 | 0.1368 | 6.63 | 5.15 | 0.4179 | 1.98 | 5.09 | 1,231,642.00 | 0.8789 | 3.30 | 1.80 | 5.97 | 23.86 | 32.35 | 2.10 | 8.21 | 0.4121 | 1.44 | 0.6405 | 53.08 | 3.04 | 19.78 | 158.32 | -13.94 | 10.39 | -- |
Data as of May 31 2024. Currency figures normalised to Qingdao Vland Biotech INC's reporting currency: Chinese Yuan Renminbi CNY
0.83%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Da Cheng Fund Management Co., Ltd.as of 31 Dec 2023 | 1.03m | 0.48% |
| Everbright PGIM Fund Management Co. Ltd.as of 31 Dec 2023 | 464.10k | 0.21% |
| Manulife TEDA Fund Management Co., Ltd.as of 31 Dec 2023 | 82.50k | 0.04% |
| Fullgoal Fund Management Co., Ltd.as of 31 Dec 2023 | 78.40k | 0.04% |
| CCB Principal Asset Management Co., Ltd.as of 29 Feb 2024 | 44.90k | 0.02% |
| China Fund Management Co., Ltd.as of 31 Dec 2023 | 31.00k | 0.01% |
| Bank of China Investment Management Co., Ltd.as of 31 Dec 2023 | 29.50k | 0.01% |
| Gfund Management Co., Ltd.as of 31 Dec 2023 | 14.78k | 0.01% |
| Baoying Fund Management Co., Ltd.as of 31 Dec 2023 | 14.40k | 0.01% |
| Penghua Fund Management Co., Ltd.as of 31 Dec 2023 | 9.90k | 0.01% |
More ▼
Data from 31 Dec 2023 - 29 Feb 2024Source: FactSet Research Systems Inc.
